Alternatives to Velvet Rx

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

From $133/mo semaglutide, $209/mo tirzepatide, all 50 states, and an explicit pregnancy/breastfeeding exclusion most competitors don't bother disclosing — the price just isn't flat, it's tiered by how many months you prepay.

Not a telehealth clinic at all — zero intake, zero video visit, because it's a manufacturer-direct pharmacy for Foundayo (orforglipron), priced on a four-tier dose ladder from $149/mo (0.8mg) through $199/mo (2.5mg) and $299/mo (5.5mg and 9mg) to $349/mo (14.5mg and 17.2mg) self-pay, that only fills a prescription your own doctor already wrote and sent to LillyDirect Pharmacy or a pharmacy of your choosing.

Coby publishes its whole dose-scaling ladder up front, which is rarer than it should be: read live on 2026-08-26, compounded semaglutide runs $159, $199, $229, then $249 and holds there, and tirzepatide runs $239, $299, $329, $379, then $439. Every rung is unchanged since early August. It also answers the two questions most sellers dodge. On video, its FAQ says outright that unless your state requires one, no video visit is needed and your provider reviews everything online. On coverage, it names the four states it does not reach — Arkansas, Louisiana, Mississippi and New Mexico — instead of staying vague. Two things go the other way. Coby's month is four weeks by its own arithmetic, since it sells a three-month bundle as twelve weeks and a six-month bundle as twenty-four, so a year is thirteen bills rather than twelve. And changing your mind costs money: canceling before the prescription reaches the pharmacy deducts a $50 non-refundable visit and clinical fee from the refund, and once it has been sent, the order cannot be changed at all.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

A high-volume general telehealth platform, not a GLP-1 specialist — $99 flat for a one-time doctor consultation with no membership, but the medication cost is billed separately and never itemized, so the real monthly total is unknown until you fill the prescription.

You cannot budget this one in advance, and that is a deliberate feature rather than an oversight. RxPepsDirect charges a flat $39 per visit for the provider review and the script; the medication is billed straight to you by Optimal Balance Pharmacy at wholesale with no markup — "typical pharmacy bill: $25 to $200" — plus $15 for FedEx overnight. No subscription, no tiers, no membership, and one visit covers up to three peptides. The trade is transparency of margin against certainty of total.

Names four specific 503A compounding pharmacy partners directly — from $150/mo semaglutide, $241/mo tirzepatide on a 6-month plan, available as injection, drops, or pills — though state coverage isn't published.

A sublingual (under-the-tongue), not injectable, GLP-1 program — $189/mo semaglutide and $319/mo tirzepatide on a 6-month prepay plan, $209/mo and $359/mo on a shorter 2-month plan — serving 34 states plus DC.